Quarter Ended Mar 31, 2022
Net sales increased 8% to a quarter record $110.5 million compared to $102.4 million.
GAAP net income (loss) was $(2.7) million, or $(0.15) per diluted share, compared to $4.2 million, or $0.20 per diluted share.
Adjusted EBITDA decreased to $8.2 million compared to $11.6 million.
For complete information regarding our financials, see our periodic filings.